Abstract
The role of antibody-based immunosuppression in liver transplant recipients remains an area in which prospective trials are needed.
MeSH terms
-
Antibodies / chemistry*
-
Antibodies / therapeutic use
-
Clinical Trials as Topic
-
Graft Survival
-
Humans
-
Immunosuppression Therapy / methods*
-
Immunosuppressive Agents / therapeutic use*
-
Liver Transplantation / adverse effects*
-
Multivariate Analysis
-
Prevalence
-
T-Lymphocytes / metabolism
-
Treatment Outcome
Substances
-
Antibodies
-
Immunosuppressive Agents